The Current Ratio as of December 2025 (TTM) for YD Bio Limited Ordinary Shares (YDES) is 0.02

According to YD Bio Limited Ordinary Shares’s latest financial reports and current stock price. The company's current Current Ratio is 0.02. This represents a change of -4.53% compared to the average of 0.02 of the last 4 quarters.

YD Bio Limited Ordinary Shares (YDES) Historical Current Ratio (quarterly & annually)

How has YDES Current Ratio performed in the past?

The mean historical Current Ratio of YD Bio Limited Ordinary Shares over the last ten years is 3.39. The current 0.02 Current Ratio has changed -49.47% with respect to the historical average. Over the past ten years (40 quarters), YDES's Current Ratio was at its highest in in the December 2023 quarter at 0.03. The Current Ratio was at its lowest in in the December 2024 quarter at 0.01.

YD Bio Limited Ordinary Shares (YDES) Current Ratio by Quarter and Year

Discovering the peaks and valleys of YD Bio Limited Ordinary Shares Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

YD Bio Limited Ordinary Shares (YDES) Average Current Ratio

How has YDES Current Ratio performed in the past?

The current Current Ratio of YD Bio Limited Ordinary Shares (YDES) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

YD Bio Limited Ordinary Shares (YDES) Current Ratio vs. Peers

How is YDES’s Current Ratio compared to its peers?

YD Bio Limited Ordinary Shares’s Current Ratio is less than Vir Biotechnology, Inc. (7.01), less than Maravai LifeSciences Holdings, Inc. (5.29), less than Theravance Biopharma, Inc. (9.48), less than Geron Corporation (5.96), less than LENZ Therapeutics, Inc. (20.54), less than Day One Biopharmaceuticals, Inc. (8.68), less than Monte Rosa Therapeutics, Inc. (7.16), less than Prime Medicine, Inc. (6.61), greater than BlackRock Technology and Private Equity Term Trust (0), less than Tyra Biosciences, Inc. (21.94),

Build a custom stock screener for YD Bio Limited Ordinary Shares (YDES) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like YD Bio Limited Ordinary Shares using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

YD Bio Limited Ordinary Shares (YDES) and other stocks custom spreadsheet templates

The easiest way to analyze a company like YD Bio Limited Ordinary Shares or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.